Bioperfectus Launches New MPXV Detection Kits for Better Control of Monkeypox Virus Outbreak
|
By LabMedica International staff writers Posted on 21 Sep 2022 |

Since January 2022, cases of monkeypox have been reported across almost 60,000 in 102 countries and regions. According to data presented by WHO, about 99% of cases in 95 locations have not been historically reported. This is the first time that cases and sustained chains of transmission have been reported in countries without direct or immediate epidemiological links to areas of West or Central Africa. Recently, the WHO stated that monkeypox was unlikely to disappear completely by itself and hence, confirmed cases of monkeypox should be reported as early as possible, although in the absence of skin or mucosal lesions, PCR can be done to diagnose infection at an early stage.
In order to assist in efforts to control the monkeypox outbreak, Jiangsu Bioperfectus Technologies Co., Ltd. (Shanghai, China) has launched four new PCR products: Monkeypox Virus (MPXV) Fast Real Time PCR Kit, Monkeypox Virus and Orthopoxvirus Real Time PCR Kit, Monkeypox Virus Genotyping Real Time PCR Kit, and Monkeypox Virus/Varicella-zoster Virus/Variola Virus Real Time PCR Kit. Combined with the company’s extraction solution and PCR system, Bioperfectus can provide a Total PCR Solution for monkeypox virus diagnosis.
The genus Orthopoxvirus of the family Poxviridae contains four viral species pathogenic to humans, indicating that the selection of species-specific oligonucleotide primers and hybridization probes is extremely important. As suggested by the FDA, highly conserved monkeypox virus targets are preferred. Bioperfectus Monkeypox Virus (MPXV) Fast Real Time PCR Kit adopts real-time PCR and hydrolysis probe techniques with two target genes to reassure the results with a fast amplification procedure specially designed for 96 samples within 30 minutes, providing a basis for quick clinical laboratory diagnosis.
Viruses belonging to the various species members of the genus have a broad host range and infect a wide variety of mammalian species, including humans. However, orthopoxviruses are immunologically cross-reactive and cross-protective, indicating that infection with any member of this genus provides protection against infection with any other member. Based on this knowledge, a person presenting with an unexplained acute skin rash, mucosal lesions or lymphadenopathy (swollen lymph nodes), the WHO recommends detection for Orthopoxvirus. Bioperfectus Monkeypox Virus and Orthopoxvirus Real Time PCR Kit supports the qualitative detection and differentiation of DNA from Monkeypox virus and Orthopoxvirus, with a housekeeping gene (RNase P) as an internal control (IC).
There are two distinct genetic clades of the monkeypox virus: the central African (Congo Basin) clade and the West African clade. The case fatality rate reported in outbreaks for the Congo Basin clade could be as high as 11%, while for west African clade, which is responsible for recent outbreaks in Nigeria, is associated with an overall lower mortality rate of consistently less than 3%. Further efforts to understand the contribution of these distinct MPXV clades will contribute to interruption of monkeypox transmission to humans, possible future outbreak responses, diagnostic test deployment and even possible outbreak-related decisions. Bioperfectus Monkeypox Virus Genotyping Real Time PCR Kit supports the detection and identification of DNA from the West African clade and the Congo Basin (Central African) clade of the Monkeypox virus.
The global eradication of smallpox was declared 35 years ago, putting an end to vaccination against smallpox. As a result, the human population has grown to become ever more unprotected every year not only from potential infection from the variola virus (VARV), but also from infection with other closely related orthopoxviruses, such as a varicella-zoster virus (VZV), monkeypox virus (MPXV). Accurate diagnosis alone may be insufficient, especially in the case of monkeypox atypical forms, which cannot be easily distinguished from VZV or VARV infections. Bioperfectus Monkeypox Virus/Varicella-zoster Virus/Variola Virus Real Time PCR Kit designs specific primers and probes based on F3L gene for Monkeypox virus, ORF38 gene for Varicella-zoster Virus, B9R/B10R gene for Variola virus to help distinguish between the infections.
Related Links:
Jiangsu Bioperfectus Technologies Co., Ltd.
Latest Molecular Diagnostics News
- Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
- Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
- Two-in-One DNA Analysis Improves Diagnostic Accuracy While Saving Time and Costs
- “Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
- New Tool Maps Chromosome Shifts in Cancer Cells to Predict Tumor Evolution
- Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
- Newly-Identified Parkinson’s Biomarkers to Enable Early Diagnosis Via Blood Tests
- New Blood Test Could Detect Pancreatic Cancer at More Treatable Stage
- Liquid Biopsy Could Replace Surgical Biopsy for Diagnosing Primary Central Nervous Lymphoma
- New Tool Reveals Hidden Metabolic Weakness in Blood Cancers
- World's First Blood Test Distinguishes Between Benign and Cancerous Lung Nodules
- Rapid Test Uses Mobile Phone to Identify Severe Imported Malaria Within Minutes
- Gut Microbiome Signatures Predict Long-Term Outcomes in Acute Pancreatitis
- Blood Test Promises Faster Answers for Deadly Fungal Infections
- Blood Test Could Detect Infection Exposure History
- Urine-Based MRD Test Tracks Response to Bladder Cancer Surgery
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more







